[go: up one dir, main page]

SE0100295D0 - New compounds - Google Patents

New compounds

Info

Publication number
SE0100295D0
SE0100295D0 SE0100295A SE0100295A SE0100295D0 SE 0100295 D0 SE0100295 D0 SE 0100295D0 SE 0100295 A SE0100295 A SE 0100295A SE 0100295 A SE0100295 A SE 0100295A SE 0100295 D0 SE0100295 D0 SE 0100295D0
Authority
SE
Sweden
Prior art keywords
new compounds
relates
present
compounds
methylbenzylamino
Prior art date
Application number
SE0100295A
Other languages
Swedish (sv)
Inventor
Mikael Dahlstroem
Karin Loevqvist
Bengt Malm
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0100295A priority Critical patent/SE0100295D0/en
Publication of SE0100295D0 publication Critical patent/SE0100295D0/en
Priority to ARP020100274A priority patent/AR032520A1/en
Priority to PCT/SE2002/000164 priority patent/WO2002060442A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to novel forms of 2, 3-dimethyl-8-(2-ethyl-6-methylbenzylamino-imidazo[1, 2-a]pyridine-6-carboxamide hydrochloride salt. Further, the present invention also relates to use of said compounds for the treatment of gastrointestinal disorders, pharmaceutical compositions containing them and processes for obtaining them.
SE0100295A 2001-02-01 2001-02-01 New compounds SE0100295D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0100295A SE0100295D0 (en) 2001-02-01 2001-02-01 New compounds
ARP020100274A AR032520A1 (en) 2001-02-01 2002-01-25 COMPOUNDS
PCT/SE2002/000164 WO2002060442A1 (en) 2001-02-01 2002-01-30 Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0100295A SE0100295D0 (en) 2001-02-01 2001-02-01 New compounds

Publications (1)

Publication Number Publication Date
SE0100295D0 true SE0100295D0 (en) 2001-02-01

Family

ID=20282797

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0100295A SE0100295D0 (en) 2001-02-01 2001-02-01 New compounds

Country Status (3)

Country Link
AR (1) AR032520A1 (en)
SE (1) SE0100295D0 (en)
WO (1) WO2002060442A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ540504A (en) 2002-11-19 2007-12-21 Altana Pharma Ag 8-Substituted imidazopyridines for the treatment of gastrointestinal disorders
CN101361738A (en) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 Imidazo[1,2-a]pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (en) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9801526D0 (en) * 1998-04-29 1998-04-29 Astra Ab New compounds

Also Published As

Publication number Publication date
AR032520A1 (en) 2003-11-12
WO2002060442A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
WO2003095455A3 (en) Substituted pyrazolopyrimidines
PL1625126T3 (en) Imidazo and thiazolopyridines as jak3 kinase inhibitors
AP2005003424A0 (en) Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders; process for their preparation and pharmaceutical compositions containing them.
SE0301700D0 (en) Novel compounds
IL187438A0 (en) Pyrrolopyridine derivatives and pharmaceutical compositions containing the same
DE60212949D1 (en) ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS
CY1109962T1 (en) Substituted 1,4,8-Triazaspiro [4,5] DECAN-2-ONE COMPOUNDS FOR OBESITY TREATMENT
GB0111186D0 (en) Novel compounds
CY1109366T1 (en) Substituted Compounds 1,4,8-Triazazepiro [4.5] Decan-2-One
WO2002048148A3 (en) Pyrazolopyridine derivatives
NO20061575L (en) Process for the preparation of renzapride and its intermediates
AP1429A (en) Citrate salt of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]- hexadeca2(11), 3,5,7,9-pentaene and pharmaceutical compositions thereof.
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
WO2002085853A3 (en) Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
SE0102716D0 (en) Novel compounds
EA200700144A1 (en) PYRIDOPYRIMIDINE DERIVATIVES, THEIR RECEIVING, THEIR APPLICATION IN THERAPY
WO2003045940A3 (en) Benzazepine derivatives and their use as 5-ht ligands
SE0100295D0 (en) New compounds
SE0100296D0 (en) New compounds
SE0100297D0 (en) New compounds
HUP0103912A3 (en) Substituted alkylpyridazinone derivatives, process for their preparation, their use for the preparation of pharmaceutical compositions with anxiolytic activity
WO2002044128A3 (en) Salicylate analogs as interleukin-4 antagonists
SE0303451D0 (en) New compounds
DE60220800D1 (en) CHIRAL DINAPSOLIN
EE05329B1 (en) GlyT-1 inhibitors, compositions containing them, their use and intermediates for their preparation